Manulife (Manufacturers Life Insurance)
AMRX icon

Manulife (Manufacturers Life Insurance)’s Amneal Pharmaceuticals AMRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Buy
88,007
+8,347
+10% +$112K ﹤0.01% 1785
2025
Q4 		$1M Sell
79,660
-2,246
-3% -$25.7K ﹤0.01% 1857
2025
Q3 		$820K Sell
81,906
-3,305
-4% -$29.7K ﹤0.01% 1968
2025
Q2 		$689K Sell
85,211
-8,042
-9% -$60.6K ﹤0.01% 2004
2025
Q1 		$781K Buy
93,253
+6,276
+7% +$52.4K ﹤0.01% 1923
2024
Q4 		$689K Sell
86,977
-2,448
-3% -$20.5K ﹤0.01% 2082
2024
Q3 		$744K Sell
89,425
-4,770
-5% -$37.3K ﹤0.01% 2070
2024
Q2 		$598K Buy
94,195
+22,850
+32% +$145K ﹤0.01% 2131
2024
Q1 		$432K Buy
71,345
+21,729
+44% +$123K ﹤0.01% 2260
2023
Q4 		$301K Sell
49,616
-1,470
-3% -$6.55K ﹤0.01% 2411
2023
Q3 		$216K Sell
51,086
-229
-0.4% -$854 ﹤0.01% 2560
2023
Q2 		$159K Buy
51,315
+6,991
+16% +$14.9K ﹤0.01% 2691
2023
Q1 		$61.6K Hold
44,324
– – ﹤0.01% 2835
2022
Q4 		$88.2K Sell
44,324
-2,765
-6% -$6.2K ﹤0.01% 2824
2022
Q3 		$95.1K Sell
47,089
-518
-1% -$1.45K ﹤0.01% 2822
2022
Q2 		$151K Buy
47,607
+910
+2% +$3.3K ﹤0.01% 2786
2022
Q1 		$195K Sell
46,697
-10,952
-19% -$48.5K ﹤0.01% 2784
2021
Q4 		$276 Sell
57,649
-545
-0.9% -$2.72K ﹤0.01% 2667
2021
Q3 		$311K Sell
58,194
-3,125
-5% -$15.7K ﹤0.01% 2642
2021
Q2 		$314K Sell
61,319
-381
-0.6% -$2.17K ﹤0.01% 2782
2021
Q1 		$415K Sell
61,700
-2,763
-4% -$15.3K ﹤0.01% 2410
2020
Q4 		$295K Buy
64,463
+684
+1% +$3.03K ﹤0.01% 2524
2020
Q3 		$247K Hold
63,779
– – ﹤0.01% 2428
2020
Q2 		$298K Sell
63,779
-16,744
-21% -$69K ﹤0.01% 2260
2020
Q1 		$280K Buy
80,523
+17,039
+27% +$72.2K ﹤0.01% 2134
2019
Q4 		$306K Sell
63,484
-500
-0.8% -$1.74K ﹤0.01% 2324
2019
Q3 		$205K Buy
63,984
+454
+0.7% +$1.58K ﹤0.01% 2569
2019
Q2 		$456K Buy
63,530
+2,173
+4% +$22.2K ﹤0.01% 2108
2019
Q1 		$869K Buy
61,357
+8,092
+15% +$107K ﹤0.01% 1774
2018
Q4 		$721K Sell
53,265
-3,927
-7% -$70.8K ﹤0.01% 1755
2018
Q3 		$1.27M Sell
57,192
-7,508
-12% -$158K ﹤0.01% 1659
2018
Q2 		$1.06M Buy
+64,700
New +$1.14M ﹤0.01% 1844

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AMRX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Amneal Pharmaceuticals (AMRX) stake by 10% in Q1 2026, buying an estimated $112K and bringing the position to 88,007 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

Manulife (Manufacturers Life Insurance) first reported a position in AMRX in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.27M in Q3 2018. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 88,007 shares of Amneal Pharmaceuticals worth $1.09M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 8,347 Amneal Pharmaceuticals shares in Q1 2026, an estimated $112K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1785 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 32 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Amneal Pharmaceuticals position peaked at $1.27M in Q3 2018.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.